Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Luis Riba
ResearcherPublications, citations & collaboration network
Luis Riba is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 12 works, 298 citations, an h-index of 7 and an i10-index of 7.
12
Works
298
Citations
7
h-index
7
i10-index
IDs:OpenAlex
How has Luis Riba's publication output changed over time?
ScholarIQpublication output · 2000–2019
Output grew300% over the shown period — from 1 works in 2000 to 4 in 2019.
1
5
4
200020182019
What are the most-cited papers on Luis Riba?
ScholarIQmost cited works
Oncotype DX® Recurrence Score as a Predictor of Response to Neoadjuvant Chemotherapy
Alison M. Pease, Luis Riba, Ryan Gruner, Nadine Tung, Ted A. James
Annals of Surgical Oncology. 201899 Citations
Comparison of breast‐conserving therapy vs mastectomy in women under age 40: National trends and potential survival implications
Stefanie P. Lazow, Luis Riba, Amulya Alapati, Ted A. James
The Breast Journal. 201953 Citations
Association between socioeconomic factors and outcomes in breast cancer
Luis Riba, Ryan Gruner, Amulya Alapati, Ted A. James
The Breast Journal. 201935 Citations
Surgical Risk Factors for the Delayed Initiation of Adjuvant Chemotherapy in Breast Cancer
Luis Riba, Ryan Gruner, Aaron Fleishman, Ted A. James
Annals of Surgical Oncology. 201833 Citations
Characterizing Response to Neoadjuvant Chemotherapy in Invasive Lobular Breast Carcinoma
Luis Riba, Teresa L. Russell, Amulya Alapati, Roger B. Davis, Ted A. James
Journal of Surgical Research. 201831 Citations
Related on ScholarIQ
Beth Israel Deaconess Medical Center
Institution
Oncotype DX® Recurrence Score as a Predictor of Response to Neoadjuvant Chemotherapy
Paper
Comparison of breast‐conserving therapy vs mastectomy in women under age 40: National trends and potential survival implications
Paper
Association between socioeconomic factors and outcomes in breast cancer
Paper
Surgical Risk Factors for the Delayed Initiation of Adjuvant Chemotherapy in Breast Cancer
Paper
Characterizing Response to Neoadjuvant Chemotherapy in Invasive Lobular Breast Carcinoma
Paper